Stock Research for CNBX


Featured Broker: Ally Invest

Get the due diligence for another stock.


CNBX Stock Chart & Research Data

The CNBX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CNBX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CNBX Due diligence Resources & Stock Charts

The CNBX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CNBX Detailed Price Forecast - CNN Money CNN View CNBX Detailed Summary - Google Finance
Yahoo View CNBX Detailed Summary - Yahoo! Finance Zacks View CNBX Stock Research & Analysis -

Stock Analysis

TradeIdeas View CNBX Trends & Analysis - Trade-Ideas Barrons View CNBX Major Holders - Barrons
NASDAQ View CNBX Call Transcripts - NASDAQ Seeking View CNBX Breaking News & Analysis - Seeking Alpha
Spotlight View CNBX Annual Report - OTC Report View CNBX OTC Short Report -
TradeKing View CNBX Fundamentals - TradeKing Charts View CNBX SEC Filings - Bar Chart
WSJ View Historical Prices for CNBX - The WSJ Morningstar View Performance/Total Return for CNBX - Morningstar
MarketWatch View the Analyst Estimates for CNBX - MarketWatch CNBC View the Earnings History for CNBX - CNBC
StockMarketWatch View the CNBX Earnings - StockMarketWatch MacroAxis View CNBX Buy or Sell Recommendations - MacroAxis
Bullish View the CNBX Bullish Patterns - American Bulls Short Pains View CNBX Short Pain Metrics -

Social Media Mentions

StockTwits View CNBX Stock Mentions - StockTwits PennyStocks View CNBX Stock Mentions - PennyStockTweets
Twitter View CNBX Stock Mentions - Twitter Invest Hub View CNBX Investment Forum News - Investor Hub
Yahoo View CNBX Stock Mentions - Yahoo! Message Board Seeking Alpha View CNBX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CNBX - Insider Cow View Insider Transactions for CNBX - Insider Cow
CNBC View CNBX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CNBX - OTC Markets
Yahoo View Insider Transactions for CNBX - Yahoo! Finance NASDAQ View Institutional Holdings for CNBX - NASDAQ

Stock Charts

FinViz View CNBX Stock Insight & Charts - StockCharts View CNBX Investment Charts -
BarChart View CNBX Stock Overview & Charts - BarChart Trading View View CNBX User Generated Charts - Trading View

Latest Financial News for CNBX

CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma
Posted on Tuesday November 08, 2022

CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related medicine, announced today that it has acquired a controlling interest in TaGeza Biopharmaceuticals Ltd. The TaGeza research team remains committed to the company, and co-founder Prof. Benjamin Dekel (MD, PhD) will continue to serve as the company's Chief Scientist; CNBX Chairman, Gabriel Yariv, to assume the position of TaGeza Biopharmaceuticals CEO.

CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy
Posted on Tuesday October 18, 2022

CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that the Company has filed a new patent application titled " COMPOSITIONS COMPRISING CANNABINOIDS AND METHODS OF USE THEREOF IN THE TREATMENT OF CANCER" under the Patent Cooperation Treaty (PCT).

CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel
Posted on Thursday October 13, 2022

CNBX Pharmaceuticals Inc. (OTC-QB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that the Company's patent application titled "COMPOSITION AND METHOD FOR TREATING CANCER WITH CANNABINOIDS" was filed on October 12, 2022 with the US Patent and Trademark Office (USPTO) and with the Israel Patent Office under a national phase of International Patent Application. National phase filing in Europe will follow.

Posted on Wednesday December 31, 1969

Stock Market & Investing Books

Enter a stock symbol to view the stock details.